Lagos, Nigeria (PANA) - Uganda, through its ministry of Health, and the Merck in the United States and Canada (MSD), Tuesday launched a national Cervical Cancer vaccination programme with GARDASIL (Human Papillomavirus Quadrivalent -- Types 6, 11, 16 and 18 -- Vaccine, Recombinant) for eligible girls 9 to 13 years of age in 12 districts of the country.
Full text...©-Panapress-04 september 2012 16:32:22-thread Health (372words)